Davis Capital Management »

Cytek Biosciences shares owned by Davis Capital Management

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Davis Capital Management from 13F filings

Historical chart of Davis Capital Management investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Davis Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Davis Capital Management

Quarter filed Position value Share count Share price at filing
2026-09-30 $66 11 6.00
2026-06-30 $53 12 4.42

More positions owned by Davis Capital Management

Schwab U.s. Broad Market Etf Etf (SCHB)
Schwab International Equity Etf Etf (SCHF)
Schwab Us Dividend Equity Etf Etf (SCHD)
Schwab U.s. Small-cap Etf Etf (SCHA)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Apple Stock (AAPL)
Vanguard Morningstar Total Stock Market Etf Etf (VTI)
Microsoft Corp Stock (MSFT)
Amazon Stock (AMZN)
Bank Of Ny Mellon Corp Stock (BNY)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Allstate Corp Stock (ALL)
Cisco Sys Stock (CSCO)
Union Pac Corp Stock (UNP)
Visa Inc Com Cl A Stock (V)

View all positions for Davis Capital Management

Top funds holding Cytek Biosciences

BlackRock
Millennium Management
Robeco Investment Management
Hillhouse Capital Advisors
Vanguard Capital Management
Geode Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Royce & Associates
Russell Investments
Acadian Asset Management
Bank of America Corporation
Vanguard Portfolio Management
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Cytek Biosciences